All In Biotech

Drug Trial Radar · NCT00127907

Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest

Comparison of Epinephrine Associated With Vasopressin vs Epinephrine Alone in the Treatment of Out-of-hospital Cardiac Arrests

Last checked: Nov 19, 2026Latest source record: Jun 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 2,416 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,416

Actual

Start

May 2, 2004

Primary completion

Oct 1, 2007

Study completion Oct 1, 2007

Sponsor

Lead sponsor
Hospices Civils de LyonAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 9, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Recent studies have suggested that arginine-vasopressin could be more effective in the treatment of cardiac arrests. The last published study did not outline obvious improvements in the prognosis of all cardiac arrests but pointed out a possible increased survival rate when arginine-vasopressin is associated with epinephrine. The aim of this study is to compare the efficacy of two successive injections of epinephrine (1 mg) with two successive injections of epinephrine associated with arginine-vasopressin (40 UI) in out-of-hospital cardiac arrests occurring in adult patients. The primary endpoint is the survival rate at hospital admission. The inclusion period lasts 18 months and 2416 patients are planned to be enrolled.

Conditions

  • Cardiac Arrest

Interventions

  • epinephrine (1 mg/1 mL)Drug

  • arginine-vasopressin (40 UI/2 mL)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Survival at hospital admission

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.